Biocon Limited has informed the Exchange regarding a press release dated December 11, 2024, titled "Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence".
Biocon Limited has informed the Exchange regarding a press release dated December 11, 2024, titled "Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence".